silybin has been researched along with Uterine Cervical Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Y; Dong, Y; Ge, Y; Li, Q; Shi, W; Zhang, Y | 1 |
| Fan, S; Ikejima, T; Li, L; Onodera, S; Qi, M; Sun, Z; Tashiro, S; Yao, G; Yu, Y | 1 |
2 other study(ies) available for silybin and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Female; HeLa Cells; Humans; Signal Transduction; Silybin; Silymarin; Uterine Cervical Neoplasms | 2012 |
P53-mediated GSH depletion enhanced the cytotoxicity of NO in silibinin-treated human cervical carcinoma HeLa cells.
Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Female; Glutathione; HeLa Cells; Humans; Nitric Oxide; Reactive Oxygen Species; Silybin; Silymarin; Structure-Activity Relationship; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2012 |